185 related articles for article (PubMed ID: 28724385)
1. Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.
Qasem H; Al-Ayadhi L; Al Dera H; El-Ansary A
Lipids Health Dis; 2017 Jun; 16(1):117. PubMed ID: 28724385
[TBL] [Abstract][Full Text] [Related]
2. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
[TBL] [Abstract][Full Text] [Related]
3. Association of social and cognitive impairment and biomarkers in autism spectrum disorders.
Alabdali A; Al-Ayadhi L; El-Ansary A
J Neuroinflammation; 2014 Jan; 11():4. PubMed ID: 24400970
[TBL] [Abstract][Full Text] [Related]
4. Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism.
Qasem H; Al-Ayadhi L; El-Ansary A
Lipids Health Dis; 2016 Aug; 15():130. PubMed ID: 27530350
[TBL] [Abstract][Full Text] [Related]
5. Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients.
El-Ansary A; Hassan WM; Qasem H; Das UN
PLoS One; 2016; 11(11):e0164153. PubMed ID: 27824861
[TBL] [Abstract][Full Text] [Related]
6. Secretagogin (SCGN) Plasma Levels and their Association with Cognitive and Social Behavior in Children with Autism Spectrum Disorder ASD).
Alhowikan AM; -Ayadhi LA; Halepoto DM
J Coll Physicians Surg Pak; 2017 Apr; 27(4):222-226. PubMed ID: 28492151
[TBL] [Abstract][Full Text] [Related]
7. Impact of Auditory Integrative Training on Transforming Growth Factor-β1 and Its Effect on Behavioral and Social Emotions in Children with Autism Spectrum Disorder.
Al-Ayadhi L; Alhowikan AM; Halepoto DM
Med Princ Pract; 2018; 27(1):23-29. PubMed ID: 29298441
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the independent and combined effects of omega-3 and vitamin B12 on phospholipids and phospholipase A2 as phospholipid hydrolyzing enzymes in PPA-treated rats as a model for autistic traits.
Alfawaz H; Bhat RS; Al-Mutairi M; Alnakhli OM; Al-Dbass A; AlOnazi M; Al-Mrshoud M; Hasan IH; El-Ansary A
Lipids Health Dis; 2018 Aug; 17(1):205. PubMed ID: 30170600
[TBL] [Abstract][Full Text] [Related]
9. A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders.
Alabdali A; Al-Ayadhi L; El-Ansary A
Behav Brain Funct; 2014 Apr; 10():14. PubMed ID: 24776096
[TBL] [Abstract][Full Text] [Related]
10. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia.
El-Ansary AK; Bacha AG; Al-Ayahdi LY
Lipids Health Dis; 2011 Apr; 10():63. PubMed ID: 21513514
[TBL] [Abstract][Full Text] [Related]
11. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.
Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A
Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522
[TBL] [Abstract][Full Text] [Related]
12. A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation.
Al-Ayadhi L; Abualnaja A; AlZarroug A; Alharbi T; Alhowikan AM; Halepoto DM; Al-Mazidi S
Neuropsychiatr Dis Treat; 2023; 19():1771-1780. PubMed ID: 37601825
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid peroxidation induces cytosolic phospholipase A2 activity: membrane effects versus enzyme phosphorylation.
Rashba-Step J; Tatoyan A; Duncan R; Ann D; Pushpa-Rehka TR; Sevanian A
Arch Biochem Biophys; 1997 Jul; 343(1):44-54. PubMed ID: 9210645
[TBL] [Abstract][Full Text] [Related]
14. CTRP3 as a novel biomarker in the plasma of Saudi children with autism.
Alhakbany M; Al-Ayadhi L; El-Ansary A
PeerJ; 2022; 10():e12630. PubMed ID: 35047232
[TBL] [Abstract][Full Text] [Related]
15. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
Xu C; Yang X; Sun L; Yang T; Cai C; Wang P; Jiang J; Qing Y; Hu X; Wang D; Wang P; Cui G; Zhang J; Li Y; Ji F; Liu C; Wan C
Psychiatry Res; 2019 Mar; 273():782-787. PubMed ID: 31207866
[TBL] [Abstract][Full Text] [Related]
16. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia.
El-Ansary AK; Bacha AG; Al-Ayahdi LY
Lipids Health Dis; 2011 Apr; 10():62. PubMed ID: 21510882
[TBL] [Abstract][Full Text] [Related]
17. Elevated Plasma X-Linked Neuroligin 4 Expression Is Associated with Autism Spectrum Disorder.
Al-Ayadhi LY; Qasem HY; Alghamdi HAM; Elamin NE
Med Princ Pract; 2020; 29(5):480-485. PubMed ID: 32155636
[TBL] [Abstract][Full Text] [Related]
18. The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder.
Ko C; Kim N; Kim E; Song DH; Cheon KA
Behav Brain Funct; 2016 Jun; 12(1):20. PubMed ID: 27350381
[TBL] [Abstract][Full Text] [Related]
19. Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children.
Abdulamir HA; Abdul-Rasheed OF; Abdulghani EA
Saudi Med J; 2016 Jan; 37(1):29-36. PubMed ID: 26739971
[TBL] [Abstract][Full Text] [Related]
20. [Sensory-psychomotor evaluation in Autism: A new tool for functional diagnosis].
Le Menn-Tripi C; Vachaud A; Defas N; Malvy J; Roux S; Bonnet-Brilhault F
Encephale; 2019 Sep; 45(4):312-319. PubMed ID: 30922517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
